Mother-to-child HIV transmission may be eliminated by 2015; malaria may be eliminated as a public health problem within a decade; TB prevalence could be halved by 2015. However, these health targets can only be achieved if current rates of scaling up expenditure on the three diseases are maintained and, ideally, further accelerated.
You are here
The Global Fund Board has approved two of the nine Round 9 proposals whose original rejection had been appealed by the applicants. The newly approved proposals are an HIV proposal from Pakistan that will cost $11.9 million and a TB proposal from Ukraine that will cost $34.6 million (costs are for the first two years). The approvals are subject to a number of requests for clarification being successfully responded to in a timely manner.
In December 2009, the Global Fund Board approved nine proposals in Wave 7 of the rolling continuation channel (RCC) funding stream, representing costs of up to $451 million over three years. Of the nine proposals, three were for HIV, four for TB and two for malaria. All approvals are conditional on the applicant responding satisfactorily to clarifications requested by the Technical Review Panel (TRP).
In Issue 111, GFO reported briefly on a Global Fund Board decision in November 2009 to further modify its Quality Assurance Policy for Pharmaceutical Products. This article provides some background information and further details of the decision.
The Board had previously approved a revised Quality Assurance Policy at its meeting in November 2008. That revised policy came into effect on 1 July 2009.
The Global Fund announced this month that a cumulative total of 1.75 million people living with HIV have been reached with antiretroviral (ARV) treatment through AIDS programs it supports, a 59 per cent increase over the totals as of a year ago.
Global Fund grants where the Principal Recipient (PR) is not a government entity are somewhat more likely to perform well, according to a recent statistical analysis published in The Lancet.
Civil society (CS) has played a key role in the design and development of the Global Fund, and in the response to AIDS, TB and malaria, but some challenges remain if the contribution of CS is to be maximised. This is the main message of a new report released by the Global Fund, “An Evolving Partnership: The Global Fund and Civil Society in the Fight Against AIDS, Tuberculosis and Malaria.”
Three organisations have jointly launched a new manual on how faith-based organisations (FBOs) in developing countries can interact with the Global Fund. “Engaging With The Global Fund To Fight AIDS, Tuberculosis and Malaria - A Primer for Faith-Based Organizations” was produced by Friends of the Global Fight Against AIDS, Tuberculosis and Malaria; World Vision; and Christian Connections for International Health.
Key decisions made by the Global Fund Board at the meeting that ended on Friday were as follows.
Physicians for Human Rights has released a Guide to Using Round 7 of the Global Fund to Fight AIDS, Tuberculosis and Malaria to Support Health Systems Strengthening. This is an extensively revised update to a health systems strengthening guide for Round 6.